|
YICHANG, China, Feb. 6, 2026 /PRNewswire/ -- Angel Yeast Group (SH600298) recently welcomed 29 employees from Indonesia to its headquarters in Yichang, China, for a six-month structured training program. The initiative is designed to develop a cohort of skilled professionals to support the commissioning and operations of Angel's Indonesia facility. As the Chinese Lunar New Year approaches, these young Indonesian trainees are not only learning yeast production techniques but are also gaining firsthand exposure to Spring Festival traditions.
In preparation for the holiday, Angel's Yichang facility has been decorated to mark the Spring Festival. As they stroll through the city, trainees see shopping malls bustling with people buying holiday goods, while traditional folk melodies fill the parks. Aqil, one of the participants, said, "Everyone here is preparing for the celebrations. Amid all the festive excitement, I can truly feel the energy and richness of the culture." Before joining Angel, Aqil worked at a local technology company. Like many young professionals, he was attracted to companies with a strong international presence. This customized training program is designed to help him transition into his new role, enhance his technical skills, and strengthen cross-cultural collaboration and teamwork. The multinational program officially began on November 26 last year at China Three Gorges University and consists of 20 days of classroom instruction followed by five months of hands-on operational training.
The Angel Indonesia project represents a key milestone in the company's international expansion. As an integral part of its global growth strategy, the project is expected to help build local industry capabilities, create job opportunities, and strengthen linkages across the broader value chain. The training program aims to encourage participants to adapt proactively to the new environment, engage in meaningful cultural exchange, and develop a solid mastery of both theoretical knowledge and practical skills, laying a strong foundation for the future plant's safe, stable, and reliable operations.
Setting up a subsidiary in Indonesia will allow Angel to take advantage of local resources, the strategic location, and tariff advantages, accelerating its expansion into neighboring Asian markets. The project, launched in 2025 in south-central Lampung Province, is located next to the joint venture partner's sugarcane mill. The site is currently under development, with completion and commissioning scheduled for 2027. The project includes a yeast production line with an annual capacity of 20,000 tons, supported by a wastewater treatment facility capable of processing 3,500 tons per day, as well as an organic fertilizer project designed to reduce waste and improve resource efficiency, with an annual output of 20,000 tons. Angel Yeast Indonesia will source large quantities of locally produced molasses, converting by-products into usable inputs while promoting cleaner production practices. Wastewater from yeast production will be treated and converted into organic fertilizer, and fine yeast by-products will be sold as animal feed, supporting local agriculture and livestock farming, while serving as a practical example of circular economy principles.
The Angel Yeast Indonesia plant is a key part of the company's global manufacturing network. For Angel, global operations extend beyond expanding production capacity; they focus on supporting the local yeast industry through technology transfer and workforce development, while contributing to growth across related value chains and creating employment opportunities. These young trainees are being prepared to become the core team of the Indonesia facility, playing an important role in enabling global operations, industrial collaboration, and cross-cultural engagement.
YICHANG, China, Feb. 6, 2026 /PRNewswire/ -- Angel Yeast Group (SH600298) recently welcomed 29 employees from Indonesia to its headquarters in Yichang, China, for a six-month structured training program. The initiative is designed to develop a cohort of skilled professionals to support the commissioning and operations of Angel's Indonesia facility. As the Chinese Lunar New Year approaches, these young Indonesian trainees are not only learning yeast production techniques but are also gaining firsthand exposure to Spring Festival traditions.
In preparation for the holiday, Angel's Yichang facility has been decorated to mark the Spring Festival. As they stroll through the city, trainees see shopping malls bustling with people buying holiday goods, while traditional folk melodies fill the parks. Aqil, one of the participants, said, "Everyone here is preparing for the celebrations. Amid all the festive excitement, I can truly feel the energy and richness of the culture." Before joining Angel, Aqil worked at a local technology company. Like many young professionals, he was attracted to companies with a strong international presence. This customized training program is designed to help him transition into his new role, enhance his technical skills, and strengthen cross-cultural collaboration and teamwork. The multinational program officially began on November 26 last year at China Three Gorges University and consists of 20 days of classroom instruction followed by five months of hands-on operational training.
The Angel Indonesia project represents a key milestone in the company's international expansion. As an integral part of its global growth strategy, the project is expected to help build local industry capabilities, create job opportunities, and strengthen linkages across the broader value chain. The training program aims to encourage participants to adapt proactively to the new environment, engage in meaningful cultural exchange, and develop a solid mastery of both theoretical knowledge and practical skills, laying a strong foundation for the future plant's safe, stable, and reliable operations.
Setting up a subsidiary in Indonesia will allow Angel to take advantage of local resources, the strategic location, and tariff advantages, accelerating its expansion into neighboring Asian markets. The project, launched in 2025 in south-central Lampung Province, is located next to the joint venture partner's sugarcane mill. The site is currently under development, with completion and commissioning scheduled for 2027. The project includes a yeast production line with an annual capacity of 20,000 tons, supported by a wastewater treatment facility capable of processing 3,500 tons per day, as well as an organic fertilizer project designed to reduce waste and improve resource efficiency, with an annual output of 20,000 tons. Angel Yeast Indonesia will source large quantities of locally produced molasses, converting by-products into usable inputs while promoting cleaner production practices. Wastewater from yeast production will be treated and converted into organic fertilizer, and fine yeast by-products will be sold as animal feed, supporting local agriculture and livestock farming, while serving as a practical example of circular economy principles.
The Angel Yeast Indonesia plant is a key part of the company's global manufacturing network. For Angel, global operations extend beyond expanding production capacity; they focus on supporting the local yeast industry through technology transfer and workforce development, while contributing to growth across related value chains and creating employment opportunities. These young trainees are being prepared to become the core team of the Indonesia facility, playing an important role in enabling global operations, industrial collaboration, and cross-cultural engagement.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Angel Yeast Indonesia Project: Strengthening Foundations through Technical Training and Building Consensus through Cultural Exchange
Research Introduces 577 Epigenetic Mechanism for Asian Skin
SHANGHAI, Feb. 7, 2026 /PRNewswire/ -- The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Paris. As a global platform supporting collaboration in dermatology, plastic surgery, and aging science, IMCAS facilitates the exchange of interdisciplinary research and clinical best practices. This year, Chinese skincare brand CHANDO participated in the congress by presenting a long-term research outcome: the identification of a novel epigenetic pathway for skin brightening, termed the 4-Butylresorcinol (577) Pigment Management Mechanism. The research presentation reflects the continued engagement of Chinese industry and research organizations in international scientific dialogue on precision skincare.
Global Forum for Scientific Exchange: CHANDO Research Presented at IMCAS
The IMCAS World Congress serves as a professional convening platform for plastic surgeons, dermatologists, and aesthetic practitioners, supporting the dissemination of medical research and clinical innovation at an international level. The event is designed to encourage professional exchange, continuing education, and the sharing of evidence-based technologies across disciplines.
At this year's congress, which hosted 225 scientific sessions and attracted 21,764 professionals, CHANDO's research was reviewed through the IMCAS scientific evaluation process. Selected for a keynote presentation in the main forum, CHANDO skin research scientist Dr. Youssef introduced the study titled "Epigenetic Skincare: A Novel Root-Cause Brightening Mechanism of 4-Butylresorcinol (577) via microRNA Regulation in Asian Populations." The presentation outlined the company's long-term research approach to the epigenetic factors influencing skin pigmentation in Asian populations.
Decoding the Biology of Asian Skin: A Targeted Research Approach to Brightening
CHANDO's research focused on three persistent challenges identified through long-term observation of Asian skin characteristics: stubborn dark spots, susceptibility to sallowness, and a fragile barrier that often leads to rebound darkening. While conventional brightening ingredients tend to take a generalized approach, CHANDO directed its research toward underlying biological mechanisms, studying how environmental factors like UV exposure influence gene expression. In his address, Dr. Youssef explained that since 2014, CHANDO has employed high-throughput sequencing and bioinformatics to analyze Asian skin. The team pinpointed a specific microRNA that plays a central role in UV-induced pigmentation by regulating three key enzymes (MITF, TYR, TYRP1) involved in melanin production.
The pivotal finding: CHANDO's signature ingredient, 4-Butylresorcinol (577), was shown in laboratory and clinical testing to inhibit this microRNA's abnormal expression, curbing melanin overproduction at its source. This mechanism differentiates 577 from conventional brightening approaches and provides a targeted strategy relevant to post-sun or post-procedure pigmentation management in Asian skin. Notably, the ingredient also demonstrated high tolerability in clinical testing, making it suitable for sensitive skin types prone to irritation. It effectively reduced dark spots and sallowness while minimizing common side effects like redness or rebound pigmentation.[1]
This recognition follows CHANDO's earlier designation as the "Global 577 Brightening Leader" by Shangpu Group, an independent research organization, based on the ingredient's technological innovation and commercial impact.[2] The IMCAS presentation represents an additional instance of consumer-facing research from China contributing to international scientific exchange.
A Decade of Science-Based Research for Asian Skin
For over ten years, CHANDO has invested in foundational research focused on the physiological characteristics of Asian skin. The 577 compound represents more than a functional ingredient—it reflects an applied research outcome derived from epigenetic study and skin biology. Today, 577 is integrated into CHANDO's Cellcrystal Whitening Radiance Series, demonstrating how laboratory research has been translated into consumer skincare applications designed for pigment management at the biological source.
Looking ahead, CHANDO has indicated its intention to continue participating in skin science research, with the goal of supporting clinically evaluated skincare development and ongoing international collaboration.
Notes:
[1] Data from third-party testing. Among 32 subjects aged 18–60 using the Cellcrystal Whitening Radiance Rejuvenating Serum for 4 weeks, instrumental measurement showed a 21.47% reduction in skin melanin and a 34.92% improvement in brightness. Results may vary individually.
[2] Shangpu Group's research, finalized April 2025, compared global market performance of 577-based facial brightening products (Jan 1–Dec 31, 2024). CHANDO was recognized as the Global 577 Brightening Leader based on market presence, technology, and product influence.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
CHANDO Presents Decade-Long Skin Brightening Research at IMCAS
